These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15929116

  • 41. [Case of bronchiolitis obliterans with rapidly progressive bronchiectasis after allogeneic peripheral blood-derived stem cell transplantation].
    Gotoh K, Nakamura T, Emura M, Sakai S, Sugio Y, Cho T.
    Nihon Kokyuki Gakkai Zasshi; 2010 Dec; 48(12):960-5. PubMed ID: 21226305
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Rash and GI symptoms on day +36.
    Weisdorf D.
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1405-6. PubMed ID: 17950925
    [No Abstract] [Full Text] [Related]

  • 44. De novo postallogeneic hematopoietic stem cell transplant membranous nephropathy.
    Numata A, Morishita Y, Mori M, Saito O, Takemoto F, Ando Y, Muto S, Yumura W, Kusano E.
    Exp Clin Transplant; 2013 Feb; 11(1):75-8. PubMed ID: 22809119
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation.
    Yang J, Cheuk DK, Ha SY, Chiang AK, Lee TL, Ho MH, Chan GC.
    Pediatr Transplant; 2012 Nov; 16(7):771-8. PubMed ID: 22905718
    [Abstract] [Full Text] [Related]

  • 47. Successful treatment of severe acute gastrointestinal graft-versus-host disease complicated by cytomegalovirus gastroenteritis with intra-arterial steroid infusion.
    Hirabayashi S, Kondo T, Oka T, Akamatsu Y, Hishizawa M, Shibata T, Kitano T, Takaori-Kondo A.
    Ann Hematol; 2016 Aug; 95(8):1373-5. PubMed ID: 27138923
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
    Mengarelli A, Iori AP, Romano A, Cerretti R, Cerilli L, De Propris MS, Fenu S, Moleti ML, De Felice L, Girelli G, Arcese W.
    Haematologica; 2003 Mar; 88(3):315-23. PubMed ID: 12651271
    [Abstract] [Full Text] [Related]

  • 51. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
    Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT.
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
    [Abstract] [Full Text] [Related]

  • 52. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Koehler MT, Howrie D, Mirro J, Neudorf S, Blatt J, Corey S, Wollman M, Kelly-Ekeroth V, Reyes J.
    Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
    [Abstract] [Full Text] [Related]

  • 53. Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease.
    Bradstock KF, Bilmon I, Kwan J, Micklethwaite K, Blyth E, Deren S, Bayley A, Gebski V, Gottlieb D.
    Biol Blood Marrow Transplant; 2015 May; 21(5):941-4. PubMed ID: 25636379
    [Abstract] [Full Text] [Related]

  • 54. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.
    Savani BN, Montero A, Srinivasan R, Singh A, Shenoy A, Mielke S, Rezvani K, Karimpour S, Childs R, Barrett AJ.
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1261-9. PubMed ID: 17162207
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kojima R, Kami M, Kim SW, Murashige N, Kishi Y, Hori A, Imataki O, Hamaki T, Sakiyama M, Masuo S, Fujisawa Y, Makimoto A, Heike Y, Tanosaki R, Takaue Y.
    Bone Marrow Transplant; 2003 Aug; 32(4):439-42. PubMed ID: 12900783
    [Abstract] [Full Text] [Related]

  • 58. Non-specific interstitial pneumonia as a manifestation of graft-versus-host disease following pediatric allogeneic hematopoietic stem cell transplantation.
    Miyagawa-Hayashino A, Sonobe M, Kubo T, Yoshizawa A, Date H, Manabe T.
    Pathol Int; 2010 Feb; 60(2):137-42. PubMed ID: 20398200
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Acute myelogenous leukemia with mediastinal and subcutaneous emphysema following chronic GVHD after allogeneic bone marrow transplantation].
    Doki N, Irisawa H, Saito Y, Sakura T, Miyawaki S.
    Rinsho Ketsueki; 2005 Sep; 46(9):1038-43. PubMed ID: 16440761
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.